[RADIATOR] AcctLogFileName alongside AccountingTable in <AuthBy SQL>
Jens Neu
jens.neu at biotronik.com
Thu May 10 01:48:39 CDT 2012
> I was quite puzzled why it does not work for you. I bet you have
> something like this in your log:
>
> ERR: Unknown keyword 'AcctLogFilename' in file.cfg line 38
>
> So use AcctLogFileName in your Handlers and it should work. Notice the
> spelling (f vs F). That's where the problem is.
>
> Thanks!
> Heikki
Hi Heikki,
unfortunately the error is in my email only, i typed this from my config
file and did not copy/paste. I'll be a little bit more verbose, here's my
current handler config, just stripped for some AcctColumnDefs. I Tried the
"AcctLogFileName %L/detail.local-testing" on various positions. The
current one is just based on my common sense. Effect is silence, no error
in the log or something (Trace is 4). "Filename %L/authlog.local-testing"
works as expected.
<Handler Client-Identifier=local-testing>
AcctLogFileName %L/detail.local-testing
<AuthLog SQL>
DBSource
dbi:Oracle:host=db.host.example.com;service_name=radiator
DBUsername radiator
DBAuth radiator
Table RADAUTHLOG
LogSuccess 1
SuccessQuery insert into RADAUTHLOG (TIME_STAMP, USERNAME,
TYPE) values (%t, '%n', 1)
LogFailure 1
FailureQuery insert into RADAUTHLOG (TIME_STAMP, USERNAME,
TYPE, REASON) values (%t, '%n', 0, %1)
</AuthLog>
<AuthLog FILE>
Identifier filelogger_local-testing
Filename %L/authlog.local-testing
LogSuccess 1
LogFailure 1
</AuthLog>
AuthByPolicy ContinueWhileAccept
<AuthBy GROUP>
AuthByPolicy ContinueWhileAccept
<AuthBy SQL>
DBSource
dbi:Oracle:host=db.host.example.com;service_name=radiator
DBUsername radiator
DBAuth radiator
AuthSelect select PASSWORD from DEVICE where
USER_NAME=%0
AccountingTable ACCOUNTING
AcctColumnDef USERNAME,User-Name
[...]
AcctColumnDef FRAMEDIPADDRESS,Framed-IP-Address
AcctFailedLogFileName %D/missedaccounting
SQLRecoveryFile %D/missedaccounting
</AuthBy>
<AuthBy DYNADDRESS>
AddressAllocator allocator.pool1
PoolHint pool1
</AuthBy>
</AuthBy>
</Handler>
www.biotronik.com
BIOTRONIK SE & Co. KG
Woermannkehre 1, 12359 Berlin, Germany
Sitz der Gesellschaft: Berlin, Registergericht: Berlin HRA 6501
Vertreten durch ihre Komplementärin:
BIOTRONIK MT SE
Sitz der Gesellschaft: Berlin, Registergericht: Berlin HRB 118866 B
Geschäftsführende Direktoren: Christoph Böhmer, Dr. Werner Braun, Dr.
Lothar Krings, Dr. Torsten Wolf
BIOTRONIK - A global manufacturer of advanced Cardiac Rhythm Management
systems and Vascular Intervention devices. Quality, innovation, and
reliability define BIOTRONIK and our growing success. We are innovators of
technologies like the first wireless remote monitoring system - Home
Monitoring®, Closed Loop Stimulation and coveted lead solutions as well as
state-of-the-art stents, balloons and guide wires for coronary and
peripheral indications. We highly invest in the development of drug
eluting devices and are leading the industry with our drug eluting
absorbable metal scaffold program.
This e-mail and the information it contains including attachments are
confidential and meant only for use by the intended recipient(s);
disclosure or copying is strictly prohibited. If you are not addressed,
but in the possession of this e-mail, please notify the sender immediately
and delete the document.
www.biotronik.com
BIOTRONIK SE & Co. KG
Woermannkehre 1, 12359 Berlin, Germany
Sitz der Gesellschaft: Berlin, Registergericht: Berlin HRA 6501
Vertreten durch ihre Komplementärin:
BIOTRONIK MT SE
Sitz der Gesellschaft: Berlin, Registergericht: Berlin HRB 118866 B
Geschäftsführende Direktoren: Christoph Böhmer, Dr. Werner Braun, Dr.
Lothar Krings, Dr. Torsten Wolf
BIOTRONIK - A global manufacturer of advanced Cardiac Rhythm Management
systems and Vascular Intervention devices. Quality, innovation, and
reliability define BIOTRONIK and our growing success. We are innovators of
technologies like the first wireless remote monitoring system - Home
Monitoring®, Closed Loop Stimulation and coveted lead solutions as well as
state-of-the-art stents, balloons and guide wires for coronary and
peripheral indications. We highly invest in the development of drug
eluting devices and are leading the industry with our drug eluting
absorbable metal scaffold program.
This e-mail and the information it contains including attachments are
confidential and meant only for use by the intended recipient(s);
disclosure or copying is strictly prohibited. If you are not addressed,
but in the possession of this e-mail, please notify the sender immediately
and delete the document.
More information about the radiator
mailing list